Search
中/EN
Contact/Message
Home
central pharmacy
Policies
Medical Institution
Franchise
Innovate
Recruit
News
Search
Home
central pharmacy
Policies
Medical Institution
Franchise
Innovate
Recruit
News
中/EN
Contact/Message
Innovate
Your current position:
Home
Innovate
International innovative drugs
Tyruko
Tyruko
departments:
神经内科
Active:
natalizumab
indication:
Tyruko是一种用于成人治疗高度活跃的多发性硬化症(MS)的药物,该疾病正在迅速恶化,或者没有通过至少一种其他疾病改良疗法(一种可以改变疾病进程的疗法)得到充分控制。
Licensor:
Sandoz GmbH
Approved Country/Region:
欧盟
Approval time:
2023-09-22